Gabelli & Co Investment Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-684,950	Closed	-$26.9M	–	305
2023 Q2	$26.9M	Buy	+684,950	New	+$24.2M	4.51%	3

Gabelli & Co Investment Advisers's ISEE Position: Q3 2023 in Review

Gabelli & Co Investment Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 684,950 shares — an estimated $26.9M sold.

Gabelli & Co Investment Advisers first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $26.9M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Gabelli & Co Investment Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 684,950 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $26.9M.
Gabelli & Co Investment Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Gabelli & Co Investment Advisers's IVERIC bio, Inc. Common Stock position peaked at $26.9M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2023, filed 8 Nov 2023.